Skip to main content
. Author manuscript; available in PMC: 2013 Oct 30.
Published in final edited form as: Am J Hypertens. 2011 Feb 10;24(5):10.1038/ajh.2011.12. doi: 10.1038/ajh.2011.12

Table 2.

Parameters of Vascular Endothelial Function Testing at baseline and 16-weeks following supplementation

Variable Placebo 2000 IU
Baseline 16 weeks p-value Baseline 16 weeks p-value
Baseline diameter (cm) 0.351±0.015 0.350±0.016 0.85 0.332±0.056 0.332±0.011 0.82
Peak diameter (cm) 0.374±0.015 0.369±0.016 0.44 0.356±0.01 0.362±0.013 0.39
Absolute change (cm) 0.023±0.003 0.018±0.002 0.15 0.025±0.003 0.029±0.003* 0.17
Time to peak vasodilation (s) 38±3 43±4 0.24 54±6 43±3 0.02

Note: P-values denote within group effects.

*

Significant (p=0.01) from Placebo 16 weeks

Significant (p=0.02) from Placebo Baseline